Reducing adverse events in older patients taking newly released drugs: Early identification of risk factors to offset clinical trial findings with limited applicability to older patients

0 avg rating
( 0 ratings by Goodreads )
 
9783639767971: Reducing adverse events in older patients taking newly released drugs: Early identification of risk factors to offset clinical trial findings with limited applicability to older patients

The majority of newly released prescription drugs target morbidities experienced by older patients, and it is older patients who are at increasing risk of experiencing an adverse drug event after being prescribed a newly released drug. The majority of new drugs are prescribed to older patients as soon as they are given regulatory approval to market. The important concern for older patients is that clinical trials of these new drugs frequently exclude participants who have co-morbidities commonly existing in older age groups, as well as excluding co-medications that are commonly taken by older patients. This book examines a method for early identification of risk factors to offset clinical trial findings with limited applicability to older patients. The method uses linked de-identified administrative health data to develop a profile of the receiving population for a newly approved drug. This patient profile can then be compared with the exclusion protocols applied in the clinical trials of that newly approved drug to support prospective identification of patient groups potentially at risk if they are prescribed that drug in the context of their co-morbidities and co-medications.

"synopsis" may belong to another edition of this title.

About the Author:

Dr Margaret Whitstock has worked as a Research Fellow and Lecturer at Deakin University, Australia. She has a long-term interest in reducing the growing numbers of adverse events associated with older patients' use of newly released prescription drugs, particularly those drugs which target chronic morbidities.

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 54.00
US$ 53.94

Convert Currency

Shipping: US$ 3.53
From Germany to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Whitstock, Margaret T.
ISBN 10: 3639767977 ISBN 13: 9783639767971
New Quantity Available: 1
Seller:
Rating
[?]

Book Description Book Condition: New. Publisher/Verlag: Scholar's Press | Early identification of risk factors to offset clinical trial findings with limited applicability to older patients | The majority of newly released prescription drugs target morbidities experienced by older patients, and it is older patients who are at increasing risk of experiencing an adverse drug event after being prescribed a newly released drug. The majority of new drugs are prescribed to older patients as soon as they are given regulatory approval to market. The important concern for older patients is that clinical trials of these new drugs frequently exclude participants who have co-morbidities commonly existing in older age groups, as well as excluding co-medications that are commonly taken by older patients. This book examines a method for early identification of risk factors to offset clinical trial findings with limited applicability to older patients. The method uses linked de-identified administrative health data to develop a profile of the receiving population for a newly approved drug. This patient profile can then be compared with the exclusion protocols applied in the clinical trials of that newly approved drug to support prospective identification of patient groups potentially at risk if they are prescribed that drug in the context of their co-morbidities and co-medications. | Format: Paperback | Language/Sprache: english | 204 pp. Bookseller Inventory # K9783639767971

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 53.94
Convert Currency

Add to Basket

Shipping: US$ 3.53
From Germany to U.S.A.
Destination, Rates & Speeds

2.

Margaret T. Whitstock
Published by SPS Okt 2015 (2015)
ISBN 10: 3639767977 ISBN 13: 9783639767971
New Taschenbuch Quantity Available: 2
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description SPS Okt 2015, 2015. Taschenbuch. Book Condition: Neu. Neuware - The majority of newly released prescription drugs target morbidities experienced by older patients, and it is older patients who are at increasing risk of experiencing an adverse drug event after being prescribed a newly released drug. The majority of new drugs are prescribed to older patients as soon as they are given regulatory approval to market. The important concern for older patients is that clinical trials of these new drugs frequently exclude participants who have co-morbidities commonly existing in older age groups, as well as excluding co-medications that are commonly taken by older patients. This book examines a method for early identification of risk factors to offset clinical trial findings with limited applicability to older patients. The method uses linked de-identified administrative health data to develop a profile of the receiving population for a newly approved drug. This patient profile can then be compared with the exclusion protocols applied in the clinical trials of that newly approved drug to support prospective identification of patient groups potentially at risk if they are prescribed that drug in the context of their co-morbidities and co-medications. 204 pp. Englisch. Bookseller Inventory # 9783639767971

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 58.19
Convert Currency

Add to Basket

Shipping: US$ 20.20
From Germany to U.S.A.
Destination, Rates & Speeds

3.

Margaret T. Whitstock
Published by SPS Okt 2015 (2015)
ISBN 10: 3639767977 ISBN 13: 9783639767971
New Taschenbuch Quantity Available: 2
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description SPS Okt 2015, 2015. Taschenbuch. Book Condition: Neu. Neuware - The majority of newly released prescription drugs target morbidities experienced by older patients, and it is older patients who are at increasing risk of experiencing an adverse drug event after being prescribed a newly released drug. The majority of new drugs are prescribed to older patients as soon as they are given regulatory approval to market. The important concern for older patients is that clinical trials of these new drugs frequently exclude participants who have co-morbidities commonly existing in older age groups, as well as excluding co-medications that are commonly taken by older patients. This book examines a method for early identification of risk factors to offset clinical trial findings with limited applicability to older patients. The method uses linked de-identified administrative health data to develop a profile of the receiving population for a newly approved drug. This patient profile can then be compared with the exclusion protocols applied in the clinical trials of that newly approved drug to support prospective identification of patient groups potentially at risk if they are prescribed that drug in the context of their co-morbidities and co-medications. 204 pp. Englisch. Bookseller Inventory # 9783639767971

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 58.19
Convert Currency

Add to Basket

Shipping: US$ 20.20
From Germany to U.S.A.
Destination, Rates & Speeds

4.

Margaret T. Whitstock
Published by Scholars' Press (2015)
ISBN 10: 3639767977 ISBN 13: 9783639767971
New Paperback Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Scholars' Press, 2015. Paperback. Book Condition: New. book. Bookseller Inventory # M3639767977

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 86.38
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

5.

Whitstock Margaret T
Published by Scholars Press, United States (2015)
ISBN 10: 3639767977 ISBN 13: 9783639767971
New Paperback Quantity Available: 1
Seller:
The Book Depository EURO
(London, United Kingdom)
Rating
[?]

Book Description Scholars Press, United States, 2015. Paperback. Book Condition: New. Language: English . Brand New Book. The majority of newly released prescription drugs target morbidities experienced by older patients, and it is older patients who are at increasing risk of experiencing an adverse drug event after being prescribed a newly released drug. The majority of new drugs are prescribed to older patients as soon as they are given regulatory approval to market. The important concern for older patients is that clinical trials of these new drugs frequently exclude participants who have co-morbidities commonly existing in older age groups, as well as excluding co-medications that are commonly taken by older patients. This book examines a method for early identification of risk factors to offset clinical trial findings with limited applicability to older patients. The method uses linked de-identified administrative health data to develop a profile of the receiving population for a newly approved drug. This patient profile can then be compared with the exclusion protocols applied in the clinical trials of that newly approved drug to support prospective identification of patient groups potentially at risk if they are prescribed that drug in the context of their co-morbidities and co-medications. Bookseller Inventory # KNV9783639767971

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 87.29
Convert Currency

Add to Basket

Shipping: US$ 3.96
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Margaret T. Whitstock
Published by SPS Okt 2015 (2015)
ISBN 10: 3639767977 ISBN 13: 9783639767971
New Taschenbuch Quantity Available: 1
Print on Demand
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)
Rating
[?]

Book Description SPS Okt 2015, 2015. Taschenbuch. Book Condition: Neu. This item is printed on demand - Print on Demand Neuware - The majority of newly released prescription drugs target morbidities experienced by older patients, and it is older patients who are at increasing risk of experiencing an adverse drug event after being prescribed a newly released drug. The majority of new drugs are prescribed to older patients as soon as they are given regulatory approval to market. The important concern for older patients is that clinical trials of these new drugs frequently exclude participants who have co-morbidities commonly existing in older age groups, as well as excluding co-medications that are commonly taken by older patients. This book examines a method for early identification of risk factors to offset clinical trial findings with limited applicability to older patients. The method uses linked de-identified administrative health data to develop a profile of the receiving population for a newly approved drug. This patient profile can then be compared with the exclusion protocols applied in the clinical trials of that newly approved drug to support prospective identification of patient groups potentially at risk if they are prescribed that drug in the context of their co-morbidities and co-medications. 204 pp. Englisch. Bookseller Inventory # 9783639767971

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 58.19
Convert Currency

Add to Basket

Shipping: US$ 34.79
From Germany to U.S.A.
Destination, Rates & Speeds